Heart failure patients are classified by ejection fraction (EF) into distinct groups: heart failure
with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction …

Background Physicians' adherence to guideline‐recommended therapy is associated with
short‐term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF) …

Examining the etiology and underlying pathophysiology of heart failure (HF) is an often
neglected but important aspect of treating the condition. Identifying an underlying cause …

Eligible outpatients with heart failure (HF) and reduced left ventricular ejection fraction
(LVEF) frequently do not receive target doses of HF medications. The Registry to Improve …

Background Heart failure (HF) trials have stringent inclusion and exclusion criteria, but
limited data exist regarding generalizability of trials. We compared patient characteristics …

It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection
fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge …

Background—Few data exist regarding contemporary care patterns for heart failure (HF) in
the outpatient setting. IMPROVE HF is a prospective cohort study designed to characterize …

Chronic heart failure (HF) occurs at any level of left ventricular ejection fraction (LVEF).
Mostly driven by clinical trial design, HF has nevertheless been dichotomized according to …

Background Comorbidities may differently affect treatment response and cause-specific
outcomes in heart failure (HF) with preserved (HFpEF) vs. mid-range/mildly-reduced …

Historically, only patients with a left ventricular ejection fraction (LVEF) of less than or equal
to 40% were considered to have heart failure (HF). However, it was later found that patients …